Synthesis and Characterization of Magnetic Molecularly Imprinted Polymer Sorbents (Fe3O4@MIPs) for Removal of Tetrabromobisphenol A
International Journal of Molecular Sciences · 08.08.2025 · 26 (16) · 7686
DOI: 10.3390/ijms26167686 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.08.2025. Verfasst von Clarissa Ciarlantini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Polybrominated Biphenyls, Molecularly Imprinted Polymers, Magnetite Nanoparticles, Molecular Imprinting. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza University of Rome.
Abstract (Originalsprache)
Tetrabromobisphenol A (TBBPA) is a flame retardant widely added to polymer products. Successful isolation of target analytes from complex natural matrices relies on extraction materials that can selectively interact with the analytes. In this context, the use of magnetic nanostructured adsorbents, such as magnetic molecularly imprinted polymer systems (MMIPs), can play a key role in both selective matrix–analyte interactions and separation processes. Here, to achieve different TBBPA loadings, Fe3O4 nanoparticles (NPs) were coated with chitosan (CS) or (3-aminopropyl) triethoxysilane (APTES). Moreover, to further promote template–NP interactions and modulate the polymeric shell thickness of MMIPs, 3,4-dihydroxyhydrocinnamic acid (HC) was covalently bonded in different amounts to APTES-functionalized MNPs. Thermal, SEM, and elemental analyses showed a different coating degree of the nanocomposites (Fe3O4@CS-MIP size d = 77 nm and Fe3O4@APTES-MIP d = 20 nm). In addition, it was confirmed that the adsorption mechanism of TBBPA on Fe3O4@APTES-HCX-MIPs was due to specific interactions between the systems and the analyte, unlike non-imprinted analogs (MNIPs). Among the developed systems, the Fe3O4@APTES-HC0.7-MIP sample showed the best extraction efficiency (85%) associated with good discharge efficiency (70%). Furthermore, this nanocomposite displayed high selectivity towards TBBPA (ε > 1) and good extraction efficiency in three consecutive cycles (67%), demonstrating great potential in the environmental field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Sapienza University of Rome, P. le Aldo Moro 5, 00185 Rome, Italy.
- Department of Industrial, Electronic and Mechanical Engineering Roma Tre University, Via Vito Volterra 62, 00146 Rome, Italy.
ORCID-Profile: Susanna Romano, Elisabetta Lacolla, Iolanda Francolini, Anna Maria Girelli, Andrea Martinelli, Antonella Piozzi
Förderung
- Sapienza University of Rome
Zitieren
APA
Ciarlantini, C., Romano, S., Amici, G. M., Lacolla, E., Francolini, I., Girelli, A. M., Martinelli, A., & Piozzi, A. (2025). Synthesis and Characterization of Magnetic Molecularly Imprinted Polymer Sorbents (Fe3O4@MIPs) for Removal of Tetrabromobisphenol A. International Journal of Molecular Sciences, 26(16), 7686. https://doi.org/10.3390/ijms26167686
Vancouver
Ciarlantini C, Romano S, Amici GM, Lacolla E, Francolini I, Girelli AM, et al. Synthesis and Characterization of Magnetic Molecularly Imprinted Polymer Sorbents (Fe3O4@MIPs) for Removal of Tetrabromobisphenol A. International Journal of Molecular Sciences. 2025;26(16):7686. doi:10.3390/ijms26167686
BibTeX
@article{Ciarlantini2025,
author = {Ciarlantini, Clarissa and Romano, Susanna and Amici, Gian Marco and Lacolla, Elisabetta and Francolini, Iolanda and Girelli, Anna Maria and Martinelli, Andrea and Piozzi, Antonella},
title = {Synthesis and Characterization of Magnetic Molecularly Imprinted Polymer Sorbents (Fe3O4@MIPs) for Removal of Tetrabromobisphenol A},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {16},
pages = {7686},
doi = {10.3390/ijms26167686}
}
EUVIMED